(Q112052448)
Statements
Omicron: A heavily mutated SARS-CoV-2 variant exhibits stronger binding to ACE2 and potently escape approved COVID-19 therapeutic antibodies (English)
0 references
7 December 2021
0 references
scientific article published on 7 December 2021